Drug manufacturer Kahira Pharmaceuticals posted financial results for the fiscal year that ended on June 30, 2014.
These results showed EGP 41.1 million net profit, with a 23.9% decline compared with EGP 53.98 million a year earlier.
The company had posted EGP 50 million net profit before tax for the first nine months of FY13/14, with a rise by 8.9% compared with EGP 46 million in the same period a year earlier.